Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Adam Lerner, MD
Boston Medical Center, USA
Principal Investigator - Amanda Cashen, MD
Wasington University School of Medicine- Division of Oncology
Principal Investigator - Andreas Neubauer, MD
University Hospital Marburg, Marburg, Germany
Principal Investigator - Andreas Viardot, MD
Universitätsklinikum Ulm, Ulm, Germany
Principal Investigator - Andrei Shustov, MD
Fred Hutchinson Cancer Research Center - Seattle Cancer Care Alliance
Principal Investigator - André Bosly, MD
Cliniques Universitaires UCL Mont Godinne, Belgium
Principal Investigator - Beata Holkova, MD
Massey Cancer Center
Principal Investigator - Bernard Poiesz, MD
Upstate Medical Univeristy Syracuse
Principal Investigator - Charles Farber, MD
Morristown Memorial Hospital
Principal Investigator - Consolación Rayon, MD
Hospital Universitario Central de Asturias, Oviedo, Spain
Principal Investigator - D. Moodley, MD
Drs Pirjol, Szpak and Moodley Inc, Durban, South Africa
Principal Investigator - David Dennis, MD
Boca Raton Clinical Research Associates
Principal Investigator - David Grinblatt, MD
Kellogg Cancer Care Center
Principal Investigator - Eliot Epner, MD
Penn State Hershey Cancer Institute
Principal Investigator - Elisabeth Perez, MD
Groupe Hospitalier Sud Réunion, France
Principal Investigator - Eric van den Neste, MD
Clinique Universitaier Saint Luc, Belgium
Principal Investigator - Fernando Camacho, MD
Bronx River Medical Associates, PC
Principal Investigator - G. Sissolak, MD
Tygerberg Hospital, Cape Town, South Africa
Principal Investigator - Georg Hess, MD
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany
Principal Investigator - Georges Fillet, MD
University of Liege, Belgium
Principal Investigator - Hanneke C. Kluin-Nelemans, MD
University Medical Center Groningen UMCG, The Netherlands
Principal Investigator - Hans-Heinrich Wolf, MD
Universitätsklinikum (AöR) der Martin-Luther-Universität Halle-Wittenberg, Halle, Germany
Principal Investigator - Juan Manuel Sancho Cia, MD
ICO Hospital Germans Trias i Pujol, Badalona, Spain
Principal Investigator - L. Verdonk, MD
Isala Clinics, Zwolle, The Netherlands
Principal Investigator - Laura Blakely, MD
Accelerated Community Oncology Reseaerch Network, Inc. (ACORN)
Principal Investigator - Lorenz Trümper, MD
Universität Göttingen, Abteilung Hämatologie und Onkologie, Göttingen, Germany
Principal Investigator - Lydia Dreosti, MD
Pretoria Academic Hospital, South Africa
Principal Investigator - Madeleine Duvic, MD
UT - M. D. Anderson Cancer Center
Principal Investigator - Maria Delioukina, MD
City of Hope National Medical Center, USA
Principal Investigator - Melissa Runge-Morris, MD
Barbara Ann Karmanos Cancer Institute
Principal Investigator - Michele Frank, MD
Cascade Cancer Center
Principal Investigator - Mohammad Tirgan, MD
Hematology Associates
Principal Investigator - Nalini Janakiraman, MD
Henry Ford Health System
Principal Investigator - Nicolas Monier, MD
Hôpital de l'Archet 1 Centre Hospitalier Universitaire (CHU) de Nice, France
Principal Investigator - O. Visser, MD
VU Medical Center, Amsterdam, The Netherlands
Principal Investigator - Owen A. O'Connor, MD
New York University Cancer Institute, USA
Principal Investigator - Peter Brown, MD
H:S Rigshospitalet, Department of Hematology, Denmark
Principal Investigator - Pier L Zinzani, MD
Università di Bologna, Italy
Principal Investigator - Ralph Boccia, MD
Center for Cancers and Blood Disorders
Principal Investigator - Sarit Assouline, MD
McGill University, Department of Oncology Clinical Research Program, Montreal, Canada
Principal Investigator - Sonia Gonzales, MD
Hospital Clinico Universitario de Santiago, Santiago de Compostella, Spain
Principal Investigator - Zale Bernstein, MD
Erie County Medical Center (Roswell Park)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
117 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Zna Middelheim
Antwerp, Belgium
- Zna Stuivenberg
Antwerp, Belgium
- Az St. Jan
Bruges, Belgium
- Clinique Universitaire Saint Luc, Service Hématologie
Brussels, Belgium
- Universitair Ziekenhuis Gent
Ghent, Belgium
- University of Liege, Divisions of Hematology and Medical Oncology
Liège, Belgium
- Cliniques Universitaires Ucl Mont Godinne, Service Hématologie
Yvoir, Belgium
- University of British Columbia
Vancouver, British Columbia, Canada
- Cha Hôpital de L'Enfant-Jésus
Québec, Quebec, Canada
- Mcgill University
Montreal, Canada
- Chc Split Clinic of Internal Diseases
Split, Croatia
- Chc Rijeka, Clinic of Internal Diseases
Zagreb, Croatia
- Chc Zagreb Clinic of Internal Diseases
Zagreb, Croatia
- Uh Dubrava Clinic of Internal Diseases
Zagreb, Croatia
- H:s Rigshospitalet, the Finsen Centre, Kat, Haematology Department 4241
Copenhagen, Denmark
- Hôpital de L'Archet, Centre Hospitalier Universitaire (chu) de Nice, Hématologie Clinique
Nice, France
- Groupe Hospitalier Sud Réunion, Site Saint-Pierre
Saint-Pierre, France
- Klinik Essen Süd, Evangelisches Krankenhaus
Essen, Germany
- Leitender Oberarzt/klinik Für Onkologie Und Hämatologie
Frankfurt, Germany
- Universität Göttingen, Abteilung Hämatologie Und Onkologie
Göttingen, Germany
- Universitätsklinikum (aör) Der Martin-Luther-Universität Halle-Wittenberg
Halle, Germany
- Asklepios Klinik St. Georg
Hamburg, Germany
- Universitätsklinikum Des Saarlandes
Homburg/Saar, Germany
- Universitätsklinikum Leipzig Aör
Leipzig, Germany
- Universitätsmedizin Der Johannes Gutenberg -Universität Mainz
Mainz, Germany
- University Hospital Marburg
Marburg, Germany
- Münchner Studienzentrum Klinikum Rechts Der Isar
München, Germany
- Klinikum Nuernberg Nord
Nuremberg, Germany
- Universitätsklinikum Rostock
Rostock, Germany
- Universitätsklinikum Ulm
Ulm, Germany
- Szt István És Szt. Laszlo
Budapest, Hungary
- Belgyógyászati Klinika
Debrecen, Hungary
- Belgyógyászati Klinika Györ
Győr, Hungary
- Belgyógyászati Klinika Es Kardiologial Központ
Szeged, Hungary
- the Soroka University Medical Center
Beersheba, Israel
- Rambam Medical Center Department of Hematology
Haifa, Israel
- Hadassah University Hospital Sharet Building Department of Hematology
Jerusalem, Israel
- Rabin Medical Center Belinson Campus
Petah Tikva, Israel
- Ospedale Sant'Orsola, Instituto Di Ematologia E Oncologia Medica
Bologna, Italy
- Ospedale Policlinico Careggi
Florence, Italy
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Dec 2008
- Primary completion
- 5 Nov 2013
- Completion
- 27 Oct 2014
- Last update posted
- 29 Oct 2021
- Registered enrollment
- 129
- Registry id
- NCT00865969
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.